SIGN UP
LOG IN
N
NBTX
Nanobiotix S.A.
3.15
-0.04-1.29%Closed15:03 04/29 EDT
OPEN/PREV CLOSE3.210/3.190
TODAY RANGE3.149-3.375
VOL3.10K
MARKET CAP149.34M
52 WEEK RANGE2.760-7.51
AVG VOL (3M)10.37K
% TURNOVER0.01%
TURNOVER--
P/E (TTM)-2.0994
% RANGE7.09%
EPS(TTM)-1.4999
P/E(FORWARD)-4.3361
P/B-72.8912
BVPS-0.0432
DIVIDEND--
P/S4.472
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP148.50M
SHARES OUTSTANDING47.43M
NEXT EARNINGS05/20-05/24
FREE FLOAT47.16M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·04/14 21:27
Nanobiotix Updates Voting Rights and Share Capital as of March 2025
TipRanks·04/14 16:57
Nanobiotix Reports Managerial Stock Transactions in April 2025
Barchart·04/14 15:15
Voting Rights and Shares Capital of the Company
TipRanks·04/10 10:47
Nanobiotix Discloses Managerial Share Acquisitions in April 2025
Benzinga·04/04 14:34
Guggenheim Maintains Buy on Nanobiotix, Lowers Price Target to $8
TipRanks·04/04 11:11
Nanobiotix price target lowered to $8 from $12 at Guggenheim
TipRanks·04/04 08:47
Nanobiotix (NBTX) Gets a Hold from UBS
TipRanks·04/04 03:55
Nanobiotix SA ADR Reports 2024 Financial Results
TipRanks·04/03 08:45
Nanobiotix: Strategic Partnerships and Clinical Advancements Drive Buy Rating
TipRanks·04/02 20:47
Nanobiotix Reports 2024 Progress and Financial Results
Seeking Alpha·04/02 20:23
Nanobiotix GAAP EPS of -€1.44
Reuters·04/02 20:15
NANOBIOTIX SA - CASH RUNWAY EXTENDED INTO MID-2026
Barchart·04/02 15:15
NANOBIOTIX Provides Business Update and Reports Full Year 2024 Financial Results
Benzinga·04/02 08:32
Earnings Scheduled For April 2, 2025
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.